trial · primary record
KP104
Glomerulonephritis
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 52 |
| Primary completion | 2028-12 |
| Primary endpoint | Percent change from Baseline in 24-hour urinary protein creatinine ratio (UPCR) at Week 24 (C3G) for participants in Stage 2 |
| Registry ID | NCT05517980 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:42.379Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05517980
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.